Multitarget Transcranial Electrical Stimulation for Freezing of Gait: A Randomized Controlled Trial.


Journal

Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688

Informations de publication

Date de publication:
11 2021
Historique:
revised: 23 07 2021
received: 08 06 2021
accepted: 26 07 2021
pubmed: 19 8 2021
medline: 17 3 2022
entrez: 18 8 2021
Statut: ppublish

Résumé

Treatments of freezing of gait (FOG) in Parkinson's disease are suboptimal. The aim of this study was to evaluate the effects of multiple sessions of transcranial direct current stimulation (tDCS) targeting the left dorsolateral prefrontal cortex and primary motor cortex (M1) on FOG. Seventy-seven individuals with Parkinson's disease and FOG were enrolled in a double-blinded randomized trial. tDCS and sham interventions comprised 10 sessions over 2 weeks followed by five once-weekly sessions. FOG-provoking test performance (primary outcome), functional outcomes, and self-reported FOG severity were assessed. Primary analyses demonstrated no advantage for tDCS in the FOG-provoking test. In secondary analyses, tDCS, compared with sham, decreased self-reported FOG severity and increased daily living step counts. Among individuals with mild-to-moderate FOG severity, tDCS improved FOG-provoking test time and self-report of FOG. Multisession tDCS targeting the left dorsolateral prefrontal cortex and M1 did not improve laboratory-based FOG-provoking test performance. Improvements observed in participants with mild-to-moderate FOG severity warrant further investigation. © 2021 International Parkinson and Movement Disorder Society.

Sections du résumé

BACKGROUND
Treatments of freezing of gait (FOG) in Parkinson's disease are suboptimal.
OBJECTIVE
The aim of this study was to evaluate the effects of multiple sessions of transcranial direct current stimulation (tDCS) targeting the left dorsolateral prefrontal cortex and primary motor cortex (M1) on FOG.
METHODS
Seventy-seven individuals with Parkinson's disease and FOG were enrolled in a double-blinded randomized trial. tDCS and sham interventions comprised 10 sessions over 2 weeks followed by five once-weekly sessions. FOG-provoking test performance (primary outcome), functional outcomes, and self-reported FOG severity were assessed.
RESULTS
Primary analyses demonstrated no advantage for tDCS in the FOG-provoking test. In secondary analyses, tDCS, compared with sham, decreased self-reported FOG severity and increased daily living step counts. Among individuals with mild-to-moderate FOG severity, tDCS improved FOG-provoking test time and self-report of FOG.
CONCLUSIONS
Multisession tDCS targeting the left dorsolateral prefrontal cortex and M1 did not improve laboratory-based FOG-provoking test performance. Improvements observed in participants with mild-to-moderate FOG severity warrant further investigation. © 2021 International Parkinson and Movement Disorder Society.

Identifiants

pubmed: 34406695
doi: 10.1002/mds.28759
doi:

Banques de données

ClinicalTrials.gov
['NCT02656316']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2693-2698

Informations de copyright

© 2021 International Parkinson and Movement Disorder Society.

Références

Weiss D, Schoellmann A, Fox MD, et al. Freezing of gait: understanding the complexity of an enigmatic phenomenon. Brain 2020;143:14-30.
Gilat M, Lígia Silva de Lima A, Bloem BR, Shine JM, Nonnekes J, Lewis SJG. Freezing of gait: promising avenues for future treatment. Parkinsonism Relat Disord 2018;52:7-16.
Nutt JG, Bloem BR, Giladi N, Hallett M, Horak FB, Nieuwboer A. Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol 2011;10:734-744.
Delgado-Alvarado M, Marano M, Santurtún A, Urtiaga-Gallano A, Tordesillas-Gutierrez D, Infante J. Nonpharmacological, nonsurgical treatments for freezing of gait in Parkinson's disease: a systematic review. Mov Disord 2020;35:204-214.
Ehgoetz Martens KA, Hall JM, Georgiades MJ, et al. The functional network signature of heterogeneity in freezing of gait. Brain 2018;141:1145-1160.
Lewis SJ, Shine JM. The next step: a common neural mechanism for freezing of gait. Neuroscientist 2016;22:72-82.
Shine JM, Matar E, Ward PB, et al. Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease. Brain 2013;136:1204-1215.
Gilat M, Dijkstra BW, D'Cruz N, Nieuwboer A, Lewis SJG. Functional MRI to study gait impairment in Parkinson's disease: a systematic review and exploratory ALE meta-analysis. Curr Neurol Neurosci Rep 2019;19:49.
Snijders AH, Takakusaki K, Debu B, et al. Physiology of freezing of gait. Ann Neurol 2016;80:644-659.
Stagg CJ, Antal A, Nitsche MA. Physiology of transcranial direct current stimulation. J ECT 2018;34:144-152.
Lefaucheur JP, Wendling F. Mechanisms of action of tDCS: a brief and practical overview. Neurophysiol Clin 2019;49:269-275.
Chhatbar PY, Kautz SA, Takacs I, et al. Evidence of transcranial direct current stimulation-generated electric fields at subthalamic level in human brain in vivo. Brain Stimul 2018;11:727-733.
Valentino F, Cosentino G, Brighina F, et al. Transcranial direct current stimulation for treatment of freezing of gait: a cross-over study. Mov Disord 2014;29:1064-1069.
Bueno MEB, do Nascimento Neto LI, Terra MB, Barboza NM, Okano AH, Smaili SM. Effectiveness of acute transcranial direct current stimulation on non-motor and motor symptoms in Parkinson's disease. Neurosci Lett 2019;696:46-51.
Putzolu M, Pelosin E, Ogliastro C, et al. Anodal tDCS over prefrontal cortex improves dual-task walking in parkinsonian patients with freezing. Mov Disord 2018;33:1972-1973.
Lee HK, Ahn SJ, Shin YM, Kang N, Cauraugh JH. Does transcranial direct current stimulation improve functional locomotion in people with Parkinson's disease? A systematic review and meta-analysis. J Neuroeng Rehabil 2019;16:84.
Dagan M, Herman T, Harrison R, et al. Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's disease. Mov Disord 2018;33:642-646.
Walton CC, Mowszowski L, Gilat M, et al. Cognitive training for freezing of gait in Parkinson's disease: a randomized controlled trial. NPJ Parkinsons Dis 2018;4:15.
Ziegler K, Schroeteler F, Ceballos-Baumann AO, Fietzek UM. A new rating instrument to assess festination and freezing gait in parkinsonian patients. Mov Disord 2010;25:1012-1018.
Herman T, Dagan M, Shema-Shiratzky S, et al. Advantages of timing the duration of a freezing of gait-provoking test in individuals with Parkinson's disease. J Neurol 2020;267:2582-2588.
Goetz CG, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 2007;22:41-47.
Podsiadlo D, Richardson S. The timed “up & go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142-148.
Weiss A, Herman T, Giladi N, Hausdorff JM. Association between community ambulation walking patterns and cognitive function in patients with Parkinson's disease: further insights into motor-cognitive links. Parkinsons Dis 2015;2015:547065.
Weiss A, Herman T, Giladi N, Hausdorff JM. New evidence for gait abnormalities among Parkinson's disease patients who suffer from freezing of gait: insights using a body-fixed sensor worn for 3 days. J Neural Transm 2015;122:403-410.
Fietzek UM, Schulz SJ, Ziegler K, Ceballos-Baumann AO. The Minimal Clinically Relevant Change of the FOG Score. J Parkinsons Dis 2020;10:325-332. https://doi.org/10.3233/JPD-191783
Olson M, Lockhart TE, Lieberman A. Motor learning deficits in Parkinson's disease (PD) and their effect on training response in gait and balance: a narrative review. Front Neurol 2019;10:62.
Heremans E, Nackaerts E, Vervoort G, Broeder S, Swinnen SP, Nieuwboer A. Impaired retention of motor learning of writing skills in patients with Parkinson's disease with freezing of gait. PLoS One 2016;11:e0148933.
Vandenbossche J, Deroost N, Soetens E, et al. Impaired implicit sequence learning in Parkinson's disease patients with freezing of gait. Neuropsychology 2013;27:28-36.
Scully AE, Hill KD, Tan D, Clark R, Pua YH, de Oliveira BIR. Measurement properties of assessments of freezing of gait severity in people with Parkinson disease: a COSMIN review. Phys Ther 2021;101. https://doi.org/10.1093/ptj/pzab009
Mancini M, Shah VV, Stuart S, et al. Measuring freezing of gait during daily-life: an open-source, wearable sensors approach. J Neuroeng Rehabil 2021;18:1.
Mancini M, Bloem BR, Horak FB, Lewis SJG, Nieuwboer A, Nonnekes J. Clinical and methodological challenges for assessing freezing of gait: future perspectives. Mov Disord 2019;34:783-790.
Montgomery GK, Reynolds NC Jr. Compliance, reliability, and validity of self-monitoring for physical disturbances of Parkinson's disease. The Parkinson's symptom diary. J Nerv Ment Dis 1990;178:636-641.
Nonnekes J, Bloem BR. Biphasic levodopa-induced freezing of gait in Parkinson's disease. J Parkinsons Dis 2020;10:1245-1248.
Ehgoetz Martens KA, Shine JM, Walton CC, et al. Evidence for subtypes of freezing of gait in Parkinson's disease. Mov Disord 2018;33:1174-1178.
Ehgoetz Martens KA, Peterson DS, Almeida QJ, Lewis SJG, Hausdorff JM, Nieuwboer A. Behavioural manifestations and associated non-motor features of freezing of gait: a narrative review and theoretical framework. Neurosci Biobehav Rev 2020;116:350-364.
Chow R, Tripp BP, Rzondzinski D, Almeida QJ. Investigating therapies for freezing of gait targeting the cognitive, limbic, and sensorimotor domains. Neurorehabil Neural Repair 2021;35:290-299.
Fasano A, Laganiere SE, Lam S, Fox MD. Lesions causing freezing of gait localize to a cerebellar functional network. Ann Neurol 2017;81:129-141.
Mosayebi-Samani M, Jamil A, Salvador R, Ruffini G, Haueisen J, Nitsche MA. The impact of individual electrical fields and anatomical factors on the neurophysiological outcomes of tDCS: a TMS-MEP and MRI study. Brain Stimul 2021;14:316-326.
Martens G, Ibáñez-Soria D, Barra A, et al. A novel closed-loop EEG-tDCS approach to promote responsiveness of patients in minimally conscious state: a study protocol. Behav Brain Res 2021;409:113311.
van Boekholdt L, Kerstens S, Khatoun A, Asamoah B, Mc LM. tDCS peripheral nerve stimulation: a neglected mode of action? Mol Psychiatry 2021;26:456-461.

Auteurs

Brad Manor (B)

Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.

Moria Dagan (M)

Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sagol School of Neuroscience and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Talia Herman (T)

Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Natalia A Gouskova (NA)

Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.

Veronique G Vanderhorst (VG)

Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.

Nir Giladi (N)

Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sagol School of Neuroscience and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Neurology, Tel Aviv University, Tel Aviv, Israel.

Thomas G Travison (TG)

Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.

Alvaro Pascual-Leone (A)

Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.
Guttman Brain Health Institute, Institut Guttmann de Neurorehabilitació, Barcelona, Spain.
Deanna and Sidney Wolk Center for Memory Health, Hebrew SeniorLife, Roslindale, MA, USA.

Lewis A Lipsitz (LA)

Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.

Jeffrey M Hausdorff (JM)

Center for the Study of Movement, Cognition, and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Sagol School of Neuroscience and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Rush Alzheimer's Disease Center and Department of Orthopedic Surgery, Rush University Medical Center, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH